Literature DB >> 16434129

Mouse model of respiratory Chlamydia pneumoniae infection for a genomic screen of subunit vaccine candidates.

Dan Li1, Alexander Borovkov, Alexander Vaglenov, Chengming Wang, Teayoun Kim, Dongya Gao, Kathryn F Sykes, Bernhard Kaltenboeck.   

Abstract

An inbred A/J mouse respiratory challenge model was validated for vaccine testing against Chlamydia (C.) pneumoniae and used to screen the C. pneumoniae genome for vaccine candidates by expression library immunization (ELI). Biolistic delivery of genetic vaccine constructs elicited Th2-like immunity that was associated with inefficient elimination of C. pneumoniae. Delivery by injection elicited protective Th1-like responses. Since biolistic delivery of pools of ORFs was used in first round screening, the screen presumably selected against potent immunogens. Nevertheless, it was sufficiently accurate to identify three weakly protective antigens among all putative C. pneumoniae ORFs. The results suggest ELI discovery of highly protective C. pneumoniae vaccine candidates requires tight control of the Th1 immunity elicited by the genetically delivered library of test antigens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434129     DOI: 10.1016/j.vaccine.2005.12.035

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Generation of High-Specificity Antibodies against Membrane Proteins Using DNA-Gold Micronanoplexes for Gene Gun Immunization.

Authors:  Debra T Hansen; Felicia M Craciunescu; Petra Fromme; Stephen A Johnston; Kathryn F Sykes
Journal:  Curr Protoc Protein Sci       Date:  2018-02-21

2.  Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays.

Authors:  Douglas M Molina; Sukumar Pal; Mathew A Kayala; Andy Teng; Paul J Kim; Pierre Baldi; Philip L Felgner; Xiaowu Liang; Luis M de la Maza
Journal:  Vaccine       Date:  2009-12-29       Impact factor: 3.641

3.  Temporal delay of peak T-cell immunity determines Chlamydia pneumoniae pulmonary disease in mice.

Authors:  Chengming Wang; Frederik W van Ginkel; Teayoun Kim; Dan Li; Yihang Li; John C Dennis; Bernhard Kaltenboeck
Journal:  Infect Immun       Date:  2008-08-25       Impact factor: 3.441

4.  Novel immune-modulator identified by a rapid, functional screen of the parapoxvirus ovis (Orf virus) genome.

Authors:  Michael J McGuire; Stephen A Johnston; Kathryn F Sykes
Journal:  Proteome Sci       Date:  2012-01-13       Impact factor: 2.480

5.  Protective antigens against glanders identified by expression library immunization.

Authors:  Gregory C Whitlock; Mark D Robida; Barbara M Judy; Omar Qazi; Katherine A Brown; Arpaporn Deeraksa; Katherine Taylor; Shane Massey; Andrey Loskutov; Alex Y Borovkov; Kevin Brown; Jose A Cano; Alfredo G Torres; D Mark Estes; Kathryn F Sykes
Journal:  Front Microbiol       Date:  2011-11-21       Impact factor: 5.640

6.  Polyclonal Antibody Production for Membrane Proteins via Genetic Immunization.

Authors:  Debra T Hansen; Mark D Robida; Felicia M Craciunescu; Andrey V Loskutov; Katerina Dörner; John-Charles Rodenberry; Xiao Wang; Tien L Olson; Hetal Patel; Petra Fromme; Kathryn F Sykes
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

7.  Novel Chlamydia pneumoniae vaccine candidates confirmed by Th1-enhanced genetic immunization.

Authors:  Yihang Li; Sudhir K Ahluwalia; Alexandre Borovkov; Andrey Loskutov; Chengming Wang; Dongya Gao; Anil Poudel; Kathryn F Sykes; Bernhard Kaltenboeck
Journal:  Vaccine       Date:  2009-12-02       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.